Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Bitler

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Nature Communications|February 14, 2018
CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activitySergey Karakashev, Hengrui Zhu, Shuai Wu, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular compositionStephanie Tanis, Manoel Lixandrao, Adriana Ivich, et al.
Cancer Research Communications|December 19, 2023
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic CancersJoseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson, et al.
Molecular Carcinogenesis|June 21, 2019
Activation of Wnt signaling promotes olaparib resistant ovarian cancerTomomi M Yamamoto, Alexandra McMellen, Zachary L Watson, et al.
Cancer Research Communications|September 23, 2024
Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive CapacityLi-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free IntervalKimberly R Jordan, Matthew J Sikora, Jill E Slansky, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant modelsLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Therapeutics|October 3, 2019
Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion MutationsPyoung Hwa Park, Tomomi M Yamamoto, Hua Li, et al.
Molecular Cancer Research : MCR|October 10, 2022
TWEAK-Fn14-RelB Signaling Cascade Promotes Stem Cell-like Features that Contribute to Post-Chemotherapy Ovarian Cancer RelapseRyne Holmberg, Mikella Robinson, Samuel F Gilbert, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinomaElizabeth R Woodruff, Courtney A Bailey, Francis To, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Nature Communications|February 14, 2018
CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activitySergey Karakashev, Hengrui Zhu, Shuai Wu, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular compositionStephanie Tanis, Manoel Lixandrao, Adriana Ivich, et al.
Cancer Research Communications|December 19, 2023
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic CancersJoseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson, et al.
Molecular Carcinogenesis|June 21, 2019
Activation of Wnt signaling promotes olaparib resistant ovarian cancerTomomi M Yamamoto, Alexandra McMellen, Zachary L Watson, et al.
Cancer Research Communications|September 23, 2024
Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive CapacityLi-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free IntervalKimberly R Jordan, Matthew J Sikora, Jill E Slansky, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant modelsLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Therapeutics|October 3, 2019
Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion MutationsPyoung Hwa Park, Tomomi M Yamamoto, Hua Li, et al.
Molecular Cancer Research : MCR|October 10, 2022
TWEAK-Fn14-RelB Signaling Cascade Promotes Stem Cell-like Features that Contribute to Post-Chemotherapy Ovarian Cancer RelapseRyne Holmberg, Mikella Robinson, Samuel F Gilbert, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinomaElizabeth R Woodruff, Courtney A Bailey, Francis To, et al.
Pageof 12